Wilterding Mark 4

4 · RxSight, Inc. · Filed Jan 30, 2026

AI-generated summary of this filing

Updated Jan 30, 2026

RxSight (RXST) CFO Mark Wilterding Receives Option and RSU Awards

What Happened

Mark Wilterding, Chief Financial Officer of RxSight, received two equity awards on January 12, 2026: a grant covering 258,770 derivative shares (stock option award) and a restricted stock unit (RSU) award covering 163,528 RSUs. Both awards are reported with an acquisition price of $0 (i.e., compensation grants, not purchases).

Key Details

Transaction date: January 12, 2026; Form 4 filed January 30, 2026 (filed well after the typical two-business-day reporting window).
Award amounts: 258,770 (option-style derivative) and 163,528 RSUs; filing shows $0 paid on grant.
Shares owned after transaction: not specified in the provided filing data.
Footnotes / vesting:
- F1 (option): 25% vests on the one-year anniversary of the Vesting Commencement Date (January 11, 2027), remainder vests monthly over the next three years (fully vested four years from Jan 11, 2026).
- F2: Each RSU equals a contingent right to receive one share of common stock.
- F3 (RSU vesting): 1/8 of the RSUs vest on February 28, 2026, then 1/8 every six months (last day of Feb and Aug) over four years.
No indication of a 10b5-1 plan, cashless exercise, sale, or tax-withholding disposition in the reported transactions.

Context

These are compensation awards (an option grant and RSUs). Options grant the right to buy shares in the future subject to vesting and any exercise price/terms; RSUs convert to shares if and when they vest. Because these are grants (not open-market purchases or sales), they reflect compensation decisions rather than an immediate insider market trade. The late filing may affect timely transparency but does not change the award terms disclosed.

Form 4

Period: 2026-01-12

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
[F1]
2026-01-12+258,770→ 258,770 total
Exercise: $10.09Exp: 2036-01-11→ Common Stock (258,770 underlying)
Award
Restricted Stock Unit
[F2][F3]
2026-01-12+163,528→ 163,528 total
→ Common Stock (163,528 underlying)

Footnotes (3)

[F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of January 11, 2026 (the "Vesting Commencement Date"), and the remaining shares subject to the options shall vesting equally monthly on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) over the following three years, such that all of the shares subject to the option shall be fully vested four years from the Vesting Commencement Date.
[F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
[F3]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one eighth (1/8th) of the shares subject to the RSU award will vest on February 28, 2026, and one eighth (1/8th) of the shares subject to the RSU award will vest every six months thereafter on the last day of February and the last day of August over a four-year period.

Signature

/s/ Bridget Balisy, as Attorney-in-Fact|2026-01-30

1 file